vs
Essent Group Ltd.（ESNT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Essent Group Ltd.的季度营收约是REPLIGEN CORP的1.6倍（$312.4M vs $197.9M），Essent Group Ltd.净利率更高（49.6% vs 6.7%，领先42.9%），REPLIGEN CORP同比增速更快（13.6% vs -0.8%），Essent Group Ltd.自由现金流更多（$848.7M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 2.3%）
Essentra PLC是一家面向全球市场的塑料及纤维产品供应商，总部位于英国牛津郡基德灵顿，业务网络覆盖全球多个区域，目前在伦敦证券交易所上市，可面向各行业客户提供多元化的相关产品及配套服务，在所属细分领域拥有较高的市场认可度。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ESNT vs RGEN — 直观对比
营收规模更大
ESNT
是对方的1.6倍
$197.9M
营收增速更快
RGEN
高出14.5%
-0.8%
净利率更高
ESNT
高出42.9%
6.7%
自由现金流更多
ESNT
多$831.1M
$17.6M
两年增速更快
RGEN
近两年复合增速
2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $312.4M | $197.9M |
| 净利润 | $155.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 59.1% | 9.0% |
| 净利率 | 49.6% | 6.7% |
| 营收同比 | -0.8% | 13.6% |
| 净利润同比 | -7.7% | 143.9% |
| 每股收益（稀释后） | $1.61 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESNTRGEN
| Q4 25 | $312.4M | $197.9M | ||
| Q3 25 | $311.8M | $188.8M | ||
| Q2 25 | $319.1M | $182.4M | ||
| Q1 25 | $317.6M | $169.2M | ||
| Q4 24 | $315.0M | $174.1M | ||
| Q3 24 | $316.6M | $154.9M | ||
| Q2 24 | $312.9M | $154.1M | ||
| Q1 24 | $298.4M | $151.3M |
净利润ESNTRGEN
| Q4 25 | $155.0M | $13.3M | ||
| Q3 25 | $164.2M | $14.9M | ||
| Q2 25 | $195.3M | $14.9M | ||
| Q1 25 | $175.4M | $5.8M | ||
| Q4 24 | $167.9M | $-30.3M | ||
| Q3 24 | $176.2M | $-654.0K | ||
| Q2 24 | $203.6M | $3.3M | ||
| Q1 24 | $181.7M | $2.1M |
毛利率ESNTRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率ESNTRGEN
| Q4 25 | 59.1% | 9.0% | ||
| Q3 25 | 63.9% | 8.9% | ||
| Q2 25 | 72.4% | 7.6% | ||
| Q1 25 | 65.2% | 3.9% | ||
| Q4 24 | 61.9% | -17.7% | ||
| Q3 24 | 65.6% | -5.1% | ||
| Q2 24 | 76.4% | 1.0% | ||
| Q1 24 | 71.6% | 1.3% |
净利率ESNTRGEN
| Q4 25 | 49.6% | 6.7% | ||
| Q3 25 | 52.7% | 7.9% | ||
| Q2 25 | 61.2% | 8.2% | ||
| Q1 25 | 55.2% | 3.4% | ||
| Q4 24 | 53.3% | -17.4% | ||
| Q3 24 | 55.6% | -0.4% | ||
| Q2 24 | 65.1% | 2.2% | ||
| Q1 24 | 60.9% | 1.4% |
每股收益（稀释后）ESNTRGEN
| Q4 25 | $1.61 | $0.24 | ||
| Q3 25 | $1.67 | $0.26 | ||
| Q2 25 | $1.93 | $0.26 | ||
| Q1 25 | $1.69 | $0.10 | ||
| Q4 24 | $1.59 | $-0.55 | ||
| Q3 24 | $1.65 | $-0.01 | ||
| Q2 24 | $1.91 | $0.06 | ||
| Q1 24 | $1.70 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $5.8B | $2.1B |
| 总资产 | $7.4B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ESNTRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务ESNTRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ESNTRGEN
| Q4 25 | $5.8B | $2.1B | ||
| Q3 25 | $5.7B | $2.1B | ||
| Q2 25 | $5.7B | $2.1B | ||
| Q1 25 | $5.7B | $2.0B | ||
| Q4 24 | $5.6B | $2.0B | ||
| Q3 24 | $5.6B | $2.0B | ||
| Q2 24 | $5.4B | $2.0B | ||
| Q1 24 | $5.2B | $2.0B |
总资产ESNTRGEN
| Q4 25 | $7.4B | $2.9B | ||
| Q3 25 | $7.4B | $2.9B | ||
| Q2 25 | $7.2B | $2.9B | ||
| Q1 25 | $7.2B | $2.9B | ||
| Q4 24 | $7.1B | $2.8B | ||
| Q3 24 | $7.1B | $2.8B | ||
| Q2 24 | $6.7B | $2.9B | ||
| Q1 24 | $6.6B | $2.8B |
负债/权益比ESNTRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $856.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $848.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 271.7% | 8.9% |
| 资本支出强度资本支出/营收 | 2.4% | 4.1% |
| 现金转化率经营现金流/净利润 | 5.52× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $1.5B | $93.9M |
8季度趋势，按日历期对齐
经营现金流ESNTRGEN
| Q4 25 | $856.1M | $25.7M | ||
| Q3 25 | $215.9M | $48.1M | ||
| Q2 25 | $189.5M | $28.6M | ||
| Q1 25 | $221.6M | $15.0M | ||
| Q4 24 | $861.5M | $39.2M | ||
| Q3 24 | $229.2M | $49.3M | ||
| Q2 24 | $188.7M | $42.2M | ||
| Q1 24 | $216.9M | $44.7M |
自由现金流ESNTRGEN
| Q4 25 | $848.7M | $17.6M | ||
| Q3 25 | $210.6M | $43.4M | ||
| Q2 25 | $188.8M | $21.5M | ||
| Q1 25 | $221.3M | $11.4M | ||
| Q4 24 | $854.8M | $33.6M | ||
| Q3 24 | $228.7M | $42.3M | ||
| Q2 24 | $187.6M | $37.4M | ||
| Q1 24 | $212.5M | $36.4M |
自由现金流率ESNTRGEN
| Q4 25 | 271.7% | 8.9% | ||
| Q3 25 | 67.5% | 23.0% | ||
| Q2 25 | 59.2% | 11.8% | ||
| Q1 25 | 69.7% | 6.8% | ||
| Q4 24 | 271.3% | 19.3% | ||
| Q3 24 | 72.2% | 27.3% | ||
| Q2 24 | 60.0% | 24.3% | ||
| Q1 24 | 71.2% | 24.0% |
资本支出强度ESNTRGEN
| Q4 25 | 2.4% | 4.1% | ||
| Q3 25 | 1.7% | 2.5% | ||
| Q2 25 | 0.2% | 3.9% | ||
| Q1 25 | 0.1% | 2.1% | ||
| Q4 24 | 2.1% | 3.2% | ||
| Q3 24 | 0.2% | 4.5% | ||
| Q2 24 | 0.3% | 3.1% | ||
| Q1 24 | 1.5% | 5.5% |
现金转化率ESNTRGEN
| Q4 25 | 5.52× | 1.93× | ||
| Q3 25 | 1.31× | 3.23× | ||
| Q2 25 | 0.97× | 1.92× | ||
| Q1 25 | 1.26× | 2.57× | ||
| Q4 24 | 5.13× | — | ||
| Q3 24 | 1.30× | — | ||
| Q2 24 | 0.93× | 12.70× | ||
| Q1 24 | 1.19× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESNT
| Mortgage Insurance Segment | $192.4M | 62% |
| Other | $120.0M | 38% |
RGEN
暂无分部数据
